| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b74c69588b99b41cf96112bd0febd968 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00893 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-01 |
| filingDate |
2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6a46da3d55fa73cae6b23c82c6c23ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2f39e8372029f80e3ebf6a74809469a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fbc4633626b4d37f422f2460ec082c1 |
| publicationDate |
2018-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018031529-A1 |
| titleOfInvention |
Systems and methods for cross-linking treatments of an eye |
| abstract |
Example eye treatments determine an area at a surface of a cornea for delivery of a cross-linking agent. The example treatments disrupt tissue at the area at the surface of the cornea up to a depth corresponding to apical layers of superficial squamous cells of the cornea, e.g., no greater than approximately 10 μm to approximately 15 μm. The example treatments apply a cross-linking agent to the area at the surface of the cornea. The cross-linking agent is transmitted through the disrupted area at a greater rate relative to non disrupted areas of the cornea. The example treatments deliver photoactivating light to the cornea. The photoactivating light activates the cross-linking agent to generate cross-linking activity in the cornea. |
| priorityDate |
2016-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |